PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

Cited by (337)

Items 301–337 of 337

  1. Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
    J. Chaves · 2024 · Queensland University of Technology
  2. A human neuronal model of sporadic Alzheimer’s disease induced by FBXO2 downregulation shows Aβ aggregation, tau hyperphosphorylation and functional network impairment
    Alicia González Díaz, Andrea Possenti, Gustavo Antonio Urrutia, Yuqi Bian, Shekhar Kedia, Dorothea Böken, Christine Maria Lim, Danilo Licastro, Benedetta Mannini, David Klenerman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Advances in induced pluripotent stem cell-based in vitro disease modeling for rare neurodegenerative disease: A narrative review
    Seung‐Yeon Lee, Hyo Jin Son, Sang Won Seo, Duk Lyul Na, Hee Jin Kim · 2024 · Precision and Future Medicine
  4. Use of CRISPR system in genetic screening to detect neurodegenerative disease
    Koyel Kar · 2024 · Elsevier eBooks
  5. A Neuroinflammatory View of Alzheimer’s Disease
    Hymie Anisman, Shawn P. Hayley, Alexander Kusnecov · 2024 · Elsevier eBooks
  6. References
    2024 · Elsevier eBooks
  7. In reply to Letter to the Editor from Paudel: Comment on “Changes in iPSC-Astrocyte Morphology Reflect Alzheimer’s Disease Patient Clinical Markers”
    N. Buckley, H. Rowland · 2025 · Stem Cells
  8. Astrocytes: Multiscale Molecular Targets for Glial Engineering and Interfaces
    Aikaterini Konstantoulaki, Roberta Fabbri, Giorgia Conte, Chiara Lazzarini, Valentina Benfenati · 2025 · Springer eBooks
  9. Applications of Induced Pluripotent Stem Cells in Neurodegenerative Disease Drug Discovery and Development with Artificial Intelligence
    Yukari Blumenthal, Keiko Imamura, Haruhisa Inoue · 2025 · Current human cell research and applications
  10. Drug Discovery and Development for Neurodegenerative Diseases Using Induced Pluripotent Stem Cells
    Haruhiko Banno, Taro Okunomiya, Haruhisa Inoue · 2025 · Stem cell biology and regenerative medicine
  11. In vitro 3D models of neuron-astrocyte interactions
    Tong Su, Zhixiang Li, Yujie Yang, Yangfan Dai, Yueqi Li, Huan Zhao · 2025 · Biochemistry and Biophysics Reports
  12. Additional file 8 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
    Yuriy Pomeshchik, Erika Velásquez, Jeovanis Gil, Oxana l. Klementieva, Ritha Gidlöf, Marie Sydoff, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Gunilla Westergren‐Thorsson et al. · 2023 · Figshare
  13. Additional file 1 of Microglial amyloid beta clearance is driven by PIEZO1 channels
    Henna Jäntti, Valeriia Sitnikova, Yevheniia Ishchenko, Anastasia Shakirzyanova, Luca Giudice, Ugidos, Irene F., Mireia Gómez‐Budia, Nea Korvenlaita, Sohvi Ohtonen, Irina Belaya et al. · 2022 · Figshare
  14. Additional file 9 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
    Yuriy Pomeshchik, Erika Velásquez, Jeovanis Gil, Oxana l. Klementieva, Ritha Gidlöf, Marie Sydoff, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Gunilla Westergren‐Thorsson et al. · 2023 · Figshare
  15. Additional file 1 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
    Yuriy Pomeshchik, Erika Velásquez, Jeovanis Gil, Oxana l. Klementieva, Ritha Gidlöf, Marie Sydoff, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Gunilla Westergren‐Thorsson et al. · 2023 · Figshare
  16. Additional file 2 of A metagenomic study of gut viral markers in amyloid-positive Alzheimer’s disease patients
    Ghorbani, Mahin, Daniel Ferreira, Silvia Maioli · 2023 · Figshare
  17. Additional file 1 of Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques
    Pranav Preman, Julia TCW, Sara Calafate, An Snellinx, María Alfonso-Triguero, Nikky Corthout, Sebastian Munck, Dietmar Rudolf Thal, Alison Goate, Bart De Strooper et al. · 2021 · Figshare
  18. Additional file 7 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
    Yuriy Pomeshchik, Erika Velásquez, Jeovanis Gil, Oxana l. Klementieva, Ritha Gidlöf, Marie Sydoff, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Gunilla Westergren‐Thorsson et al. · 2023 · Figshare
  19. Additional file 1 of iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype
    Sullivan, Michael A., Lane, Samuel D., André D. J. McKenzie, Sarah R. Ball, Sunde, Margaret, Neely, G. Gregory, Moreno, Cesar L., Alexandra Maximova, Eryn L. Werry, Michael Kassiou · 2024 · Figshare
  20. Additional file 1 of Comparison of two protocols for the generation of iPSC-derived human astrocytes
    Patrycja Mulica, Carmen Venegas, Zied Landoulsi, Katja Badanjak, Sylvie Delcambre, Maria Tziortziou, Soraya Hezzaz, Jenny Ghelfi, Semra Smajić, Jens Christian Schwamborn et al. · 2023 · Figshare
  21. Modeling Late-Onset Sporadic Alzheimer’s Disease Using Patient-Derived Cells: A Review
    Alisar Katbe, Ismaïla Diagne, Gilbert Bernier · 2026 · Neurology International
  22. Glial and Neuronal Alzheimer's Disease-Related Alterations Reproduced in Human Induced Pluripotent Stem Cells With Presenilin-1 Mutation
    Davide Comolli, Elisa Murari, Milica Cerovic, Liviu Soltuzu, Wenjie Liao, Aurora Bianchi, Serena Seminara, Ilaria Craparotta, Stefano Fumagalli, Claudia Balducci et al. · 2026 · Research Square
  23. Investigating the effects of post-exercise serum treatments on APP processing in iPSC-derived neurons and astrocytes
    Richard J. Elsworthy, Felicity S. E. Spencer, S. Allen, Connor Dunleavy, Martin Whitham, Samuel J.E. Lucas, Eric James Hill, Sarah Aldred · 2026 · The International Journal of Biochemistry & Cell Biology
  24. Lactate and cognition: a dual modulator
    Wen Yang, Yu Xu, Kunhua Wang · 2026 · Frontiers in Molecular Neuroscience
  25. Reprogramming of neuronal genome function and phenotype by astrocytes
    Boxun Li, Kevin T. Hagy, Alexias Safi, M Beer, Alejandro Barrera, Sara Geraghty, Ruhi Rai, Alyssa N. Pederson, Samuel J. Reisman, Michael I Love et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Amyloid precursor protein derivatives differentially alter the microRNA cargo of astrocyte-derived extracellular vesicles
    Aimee J. Chu, Anna Erlandsson, Joanna M. Williams · 2026 · Neuroscience
  27. IFNγ alters the aberrant phenotype of α-synuclein–treated microglia reducing the detrimental impact of their secretome on dopaminergic neurons
    Jonna Niskanen, Vili Hakosalo, Wilhelmiina Hämäläinen, Sara Kälvälä, Mervi T. Hyvönen, Yinjia Zhang, Kelvin C. Luk, Jari Koıstınaho, Marko Lehtonen, Gundars Goldsteins et al. · 2026 · Neuroscience
  28. Use of nanoliposomes rich in omega-3 for the prevention of neurodegenerative diseases : bioavailability in vivo and in cortical neurons
    Elodie Passeri · 2021 · theses.fr (ABES)
  29. Etude des mécanismes physiοpathοlοgiques de la maladie d'Alzheimer : appοrt de l'étude des variants du gène SΟRL1
    Romain Castelot · 2024 · theses.fr (ABES)
  30. Length-dependent hypercontractility decoupled from cellular adaptations is the initial phenotype in MYBPC3-haploinsufficient iPSC-derived engineered cardiac tissues
    Tomi Tuomainen, Maike Mona Širinov, Mina Rabiee, Eloi Schmauch, Jussi T. Koivumäki, Kyriaki Galani, M Kellis, Johanna Kuusisto, Robert S. Leigh, Nikolay Naumenko et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Synaptic dysfunction as a major driver in Alzheimer's disease: Beyond the amyloid paradigm
    Natalia Mierzwa, Michalina Wężyk · 2026 · Neuroscience & Biobehavioral Reviews
  32. Air-Liquid interface midbrain organoids model the pathological features of Parkinson’s disease
    Sara Kälvälä, Polina A. Abushik, Mohammad Rezaie, Antonios Dougalis, Jari Koıstınaho, Maria Gardberg, Kelvin C. Luk, Tarja Malm, Anssi Pelkonen, Šárka Lehtonen · 2026 · Neuroscience
  33. Written in the Stars: Astrocyte Biology From Evolution to Disease
    Carmen Falcone, Lut Arckens, Monica Baiula, Andrea Bedini, Riccardo Bocchi, Matthew James Broadhead, Marco Caprini, Fabio Cavaliere, Fabrizia Cesca, Helena Haque Chowdhury et al. · 2026 · Acta Physiologica
  34. Entorhinal Astrocyte Transplants Restore Spatial Exploration and Alleviate Amyloid‐Beta Pathology in Alzheimer's Mice
    Feifei Wu, Jihua Fan, Xiang Zhou, Zhiqi Yang, Mingyue Gong, Mingzhu Huang, Zhenlu Cai, Shaofan Yang, Teng Teng, Chuanyan Yang et al. · 2026 · Advanced Science
  35. Towards Improved P2X7R Cellular Models for Alzheimer’s Disease Drug Discovery
    Charleigh T. A. Agius, André D. J. McKenzie, Kim Woollett, Eryn L. Werry, Michael Kassiou · 2026 · ACS Chemical Neuroscience
  36. Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome
    Gabriel Burdman, Marco Hanna, Adriana Yndart, Arti Vashist, Madepalli Krishnappa Lakshmana · 2026 · Cells
  37. Transcriptomic and phenotypic characterization of Alzheimer’s disease risk genes in neurons and astrocytes highlights shared and cell type specific cellular mechanisms
    Caia S. Dominicus, Diego Peretti, Geraldine Rodschinka, Samuel Ogden, Juliette Steer, Melissa Leija‐Salazar, Adib Miraki Feriz, Claudia Feng, Shikha Kataria, Jing Su et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)